[Late thrombo-embolic complications after heart valve prosthesis].
A follow-up study of 444 patients with artificial heart valves of different makes demonstrated increased wear and thrombogenic properties of the hemispheric MKC-27 prosthesis, used in mitral position, over 5 years of follow-up. High risk of thrombo-embolic complications is related to interrupted anticoagulant treatment. Their rate could be reduced through improving the quality of anticoagulant treatment, i.e. continuous administration of anticoagulants under adequate monitoring.
Chernov
V A
VA
Torbina
A M
AM
Solov'eva
G M
GM
D000925:Anticoagulants / Q000627:therapeutic use; D001021:Aortic Valve / Q000601:surgery; D006349:Heart Valve Diseases / Q000601:surgery*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008943:Mitral Valve / Q000601:surgery; D011182:Postoperative Care; D011183:Postoperative Complications / Q000209:etiology* / Q000517:prevention & control; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control; D014261:Tricuspid Valve / Q000601:surgery
D000925:Anticoagulants
Pozdnie tromboembolicheskie oslozhneniia pri protezirovanii klapanov serdtsa.